The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus ; volume:8 ; number:1 ; day:6 ; month:2 ; year:2018 ; pages:1-10 ; date:12.2018
Scientific reports ; 8, Heft 1 (6.2.2018), 1-10, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Yeo, Won-Sik
- Beteiligte Personen und Organisationen
-
Arya, Rekha
Kim, Kyeong Kyu
Jeong, Hyunyoung
Cho, Kyu Hong
Bae, Taeok
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-20617-5
- URN
-
urn:nbn:de:1111-20180328787
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yeo, Won-Sik
- Arya, Rekha
- Kim, Kyeong Kyu
- Jeong, Hyunyoung
- Cho, Kyu Hong
- Bae, Taeok
- SpringerLink (Online service)
Ähnliche Objekte (12)
A systematic analysis of FDA-approved anticancer drugs
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
FDA-approved disulfiram as a novel treatment for aggressive leukemia
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
A systematic analysis of FDA-approved anticancer drugs
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
FDA-approved disulfiram as a novel treatment for aggressive leukemia
Identification of FDA-approved drugs targeting the Farnesoid X Receptor
Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
A systematic analysis of FDA-approved anticancer drugs
Classification of anticancer drugs: an update with FDA- and EMA-approved drugs
Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs
The First FDA-Approved Antibody-Drug Conjugate
Repurposing FDA-approved drugs for anti-aging therapies
Evaluierung von FDA-approved Drugs gegen das Humane Cytomegalievirus
FDA‐approved drugs featuring macrocycles or medium‐sized rings
Synthesis of the First FDA-Approved HIV Protease Inhibitor
Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus
FDA-approved disulfiram as a novel treatment for aggressive leukemia
Identification of FDA-approved drugs targeting the Farnesoid X Receptor